Discordant American College of Physicians and international rheumatology guidelines for gout management: consensus statement of the Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN)
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Discordant American College of Physicians and international rheumatology guidelines for gout management: consensus statement of the Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN)
Authors
Keywords
-
Journal
Nature Reviews Rheumatology
Volume 13, Issue 9, Pages 561-568
Publisher
Springer Nature
Online
2017-08-10
DOI
10.1038/nrrheum.2017.126
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- To Treat or Not to Treat (to Target) in Gout
- (2016) Tuhina Neogi et al. ANNALS OF INTERNAL MEDICINE
- The Long and Winding Road to Clinical Guidelines on the Diagnosis and Management of Gout
- (2016) Robert M. McLean ANNALS OF INTERNAL MEDICINE
- Management of Gout: A Systematic Review in Support of an American College of Physicians Clinical Practice Guideline
- (2016) Paul G. Shekelle et al. ANNALS OF INTERNAL MEDICINE
- Management of Acute and Recurrent Gout: A Clinical Practice Guideline From the American College of Physicians
- (2016) Amir Qaseem et al. ANNALS OF INTERNAL MEDICINE
- THU0537 Clinical Response of Tophus and Flares To Extended Use of Lesinurad in Combination with A Xanthine Oxidase Inhibitor in Patients with Gout
- (2016) T. Bardin et al. ANNALS OF THE RHEUMATIC DISEASES
- THU0495 Examination of Serum Uric Acid (Sua) Lowering and Safety with Extended Treatment with Lesinurad and Allopurinol in Subjects with Gout
- (2016) K.G. Saag et al. ANNALS OF THE RHEUMATIC DISEASES
- Treat-to-target (T2T) recommendations for gout
- (2016) U Kiltz et al. ANNALS OF THE RHEUMATIC DISEASES
- 2016 updated EULAR evidence-based recommendations for the management of gout
- (2016) P Richette et al. ANNALS OF THE RHEUMATIC DISEASES
- Trends in Gout and Rheumatoid Arthritis Hospitalizations in the United States, 1993-2011
- (2016) Sian Yik Lim et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Factors influencing the crystallization of monosodium urate: a systematic literature review
- (2015) Ashika Chhana et al. BMC MUSCULOSKELETAL DISORDERS
- An Observational Study of Gout Prevalence and Quality of Care in a National Australian General Practice Population
- (2015) P. C. Robinson et al. JOURNAL OF RHEUMATOLOGY
- Comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: analyses from large U.S. managed care cohort
- (2015) Jasvinder A Singh et al. ARTHRITIS RESEARCH & THERAPY
- Flare frequency, healthcare resource utilisation and costs among patients with gout in a managed care setting: a retrospective medical claims-based analysis
- (2015) Robert Jackson et al. BMJ Open
- Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study
- (2015) Tai-Ming Ko et al. BMJ-British Medical Journal
- Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study
- (2015) Tai-Ming Ko et al. BMJ-British Medical Journal
- Cost-Effectiveness of Allopurinol and Febuxostat for the Management of Gout
- (2014) Eric Jutkowitz et al. ANNALS OF INTERNAL MEDICINE
- Comorbidities in patients with gout prior to and following diagnosis: case-control study
- (2014) Chang-Fu Kuo et al. ANNALS OF THE RHEUMATIC DISEASES
- The impact of gout on patient’s lives: a study of African-American and Caucasian men and women with gout
- (2014) Jasvinder A Singh ARTHRITIS RESEARCH & THERAPY
- The Development of Clinical Practice Guidelines and Guidance Statements of the American College of Physicians: Summary of Methods
- (2013) Amir Qaseem ANNALS OF INTERNAL MEDICINE
- Revisiting comorbidities in gout: a cluster analysis
- (2013) Pascal Richette et al. ANNALS OF THE RHEUMATIC DISEASES
- Managing gout needs more than drugs: ‘Il faut le savoir-faire, l'Art et la manière’
- (2013) Frédéric Lioté et al. ANNALS OF THE RHEUMATIC DISEASES
- Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative
- (2013) Francisca Sivera et al. ANNALS OF THE RHEUMATIC DISEASES
- How to Decide Whether a Clinical Practice Guideline Is Trustworthy
- (2013) David F. Ransohoff et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Exploratory Study of Radiographic Change in Patients With Tophaceous Gout Treated With Intensive Urate-Lowering Therapy
- (2013) Nicola Dalbeth et al. ARTHRITIS CARE & RESEARCH
- Tophus burden reduction with pegloticase: results from phase 3 randomized trials and open-label extension in patients with chronic gout refractory to conventional therapy
- (2013) Herbert SB Baraf et al. ARTHRITIS RESEARCH & THERAPY
- Long-term safety of pegloticase in chronic gout refractory to conventional treatment
- (2012) Michael A Becker et al. ANNALS OF THE RHEUMATIC DISEASES
- Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational study
- (2012) Frances Rees et al. ANNALS OF THE RHEUMATIC DISEASES
- Starting dose is a risk factor for allopurinol hypersensitivity syndrome: A proposed safe starting dose of allopurinol
- (2012) Lisa K. Stamp et al. ARTHRITIS AND RHEUMATISM
- Evaluation of Health Care Costs and Utilization Patterns for Patients With Gout
- (2012) Haesuk Park et al. CLINICAL THERAPEUTICS
- Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: Results from a cross-sectional survey
- (2012) Puja P Khanna et al. Health and Quality of Life Outcomes
- Improved Health-related Quality of Life and Physical Function in Patients with Refractory Chronic Gout Following Treatment with Pegloticase: Evidence from Phase III Randomized Controlled Trials
- (2012) VIBEKE STRAND et al. JOURNAL OF RHEUMATOLOGY
- 2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis
- (2012) Dinesh Khanna et al. ARTHRITIS CARE & RESEARCH
- 2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia
- (2012) Dinesh Khanna et al. ARTHRITIS CARE & RESEARCH
- Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional Treatment
- (2011) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cellular characterization of the gouty tophus: A quantitative analysis
- (2010) Nicola Dalbeth et al. ARTHRITIS AND RHEUMATISM
- The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
- (2010) Michael A Becker et al. ARTHRITIS RESEARCH & THERAPY
- Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis
- (2009) Rachel Halpern et al. CURRENT MEDICAL RESEARCH AND OPINION
- Clinical Efficacy and Safety of Successful Longterm Urate Lowering with Febuxostat or Allopurinol in Subjects with Gout
- (2009) M. A. BECKER et al. JOURNAL OF RHEUMATOLOGY
- Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study
- (2009) H. R. Schumacher et al. RHEUMATOLOGY
- Dual energy computed tomography in tophaceous gout
- (2008) H K Choi et al. ANNALS OF THE RHEUMATIC DISEASES
- Mechanisms of bone erosion in gout: a quantitative analysis using plain radiography and computed tomography
- (2008) N Dalbeth et al. ANNALS OF THE RHEUMATIC DISEASES
- Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: A 28-week, phase III, randomized, double-blind, parallel-group trial
- (2008) H. RALPH Schumacher et al. ARTHRITIS AND RHEUMATISM
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now